Epidemiology of drug-induced liver injury
The incidence rate of drug-induced liver injury (DILI) is increasing year by year, and DILI has become one of the common liver diseases in clinical practice and has attracted the attention of the whole world. It is known that a variety of drugs, including Chinese herbal medicine and dietary suppleme...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | ZH |
Publicado: |
Editorial Department of Journal of Clinical Hepatology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3fe9e20322944ae4bab52c8a322be939 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3fe9e20322944ae4bab52c8a322be939 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3fe9e20322944ae4bab52c8a322be9392021-11-17T10:33:54ZEpidemiology of drug-induced liver injury1001-5256https://doaj.org/article/3fe9e20322944ae4bab52c8a322be9392021-11-01T00:00:00Zhttp://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.11.002https://doaj.org/toc/1001-5256The incidence rate of drug-induced liver injury (DILI) is increasing year by year, and DILI has become one of the common liver diseases in clinical practice and has attracted the attention of the whole world. It is known that a variety of drugs, including Chinese herbal medicine and dietary supplements, can cause various types of acute or chronic liver injury, and acute liver failure may occur in severe cases, leading to death or liver transplantation. This article elaborates on the global prevalence of DILI and the distribution of common suspected drugs.LI XiaoyunEditorial Department of Journal of Clinical HepatologyarticleDiseases of the digestive system. GastroenterologyRC799-869ZHLinchuang Gandanbing Zazhi, Vol 37, Iss 11, Pp 2510-2514 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
ZH |
topic |
Diseases of the digestive system. Gastroenterology RC799-869 |
spellingShingle |
Diseases of the digestive system. Gastroenterology RC799-869 LI Xiaoyun Epidemiology of drug-induced liver injury |
description |
The incidence rate of drug-induced liver injury (DILI) is increasing year by year, and DILI has become one of the common liver diseases in clinical practice and has attracted the attention of the whole world. It is known that a variety of drugs, including Chinese herbal medicine and dietary supplements, can cause various types of acute or chronic liver injury, and acute liver failure may occur in severe cases, leading to death or liver transplantation. This article elaborates on the global prevalence of DILI and the distribution of common suspected drugs. |
format |
article |
author |
LI Xiaoyun |
author_facet |
LI Xiaoyun |
author_sort |
LI Xiaoyun |
title |
Epidemiology of drug-induced liver injury |
title_short |
Epidemiology of drug-induced liver injury |
title_full |
Epidemiology of drug-induced liver injury |
title_fullStr |
Epidemiology of drug-induced liver injury |
title_full_unstemmed |
Epidemiology of drug-induced liver injury |
title_sort |
epidemiology of drug-induced liver injury |
publisher |
Editorial Department of Journal of Clinical Hepatology |
publishDate |
2021 |
url |
https://doaj.org/article/3fe9e20322944ae4bab52c8a322be939 |
work_keys_str_mv |
AT lixiaoyun epidemiologyofdruginducedliverinjury |
_version_ |
1718425604437573632 |